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CORRECTION
ATM Gene Mutations Result in Both Recessive
and Dominant Expression Phenotypes
of Genes and MicroRNAs
Denis A. Smirnov and Vivian G. Cheung*
(American Journal of Human Genetics 83, 243–253; August 2008)
When the manuscript was originally published in the August 2008 issue, common microRNA nomenclature synonyms
were removed to conform to journal style. Unfortunately, this rendered the manuscript difﬁcult to ﬁnd in PubMed. The
abstract is being republished here with the common synonyms added to ensure efﬁcient retrieval from PubMed:
The deﬁning characteristic of recessive disorders is the absence of disease in heterozygous carriers of the mutant alleles.
However, it has been recognized that recessive carriers may differ from noncarriers in some phenotypes. Here, we studied
ataxia telangiectasia (AT), a classical recessive disorder caused by mutations in the ataxia telangiectasia mutated (ATM)
gene. We compared the gene and microRNA expression phenotypes of noncarriers, AT carriers who have one copy of
the ATM mutations, and AT patients with two copies of ATM mutations. We found that some phenotypes are more
similar between noncarriers and AT carriers compared to AT patients, as expected for a recessive disorder. However, for
some expression phenotypes, AT carriers are more similar to the patients than to the noncarriers. Analysis of one of these
expression phenotypes, TNFSF4 level, allowed us to uncover a regulatory pathway where ATM regulates TNFSF4 expres-
sion through MIRN125B (also known as miR-125b or miR125b). In AT carriers and AT patients, this pathway is
disrupted. As a result, the level of MIRN125B is lower and the level of its target gene, TNFSF4, is higher than in noncar-
riers. A decreased level of MIRN125B is associated with breast cancer, and an elevated level of TNFSF4 is associated with
atherosclerosis. Thus, our ﬁndings provide a mechanistic suggestion for the increased risk of breast cancer and heart
disease in AT carriers. By integrating molecular and computational analyses of gene and microRNA expression, we
show the complex consequences of a human gene mutation.
The journal regrets this error.
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